Does RUXOLITINIB Cause Hypoaesthesia? 436 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 436 reports of Hypoaesthesia have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.6% of all adverse event reports for RUXOLITINIB.
436
Reports of Hypoaesthesia with RUXOLITINIB
0.6%
of all RUXOLITINIB reports
31
Deaths
103
Hospitalizations
How Dangerous Is Hypoaesthesia From RUXOLITINIB?
Of the 436 reports, 31 (7.1%) resulted in death, 103 (23.6%) required hospitalization, and 8 (1.8%) were considered life-threatening.
Is Hypoaesthesia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 436 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Hypoaesthesia?
ADALIMUMAB (7,423)
ETANERCEPT (4,497)
METHOTREXATE (4,175)
RITUXIMAB (3,605)
TOFACITINIB (3,324)
PREDNISONE (3,239)
TOCILIZUMAB (3,238)
FINGOLIMOD (3,180)
LENALIDOMIDE (3,127)
SECUKINUMAB (3,079)
Which RUXOLITINIB Alternatives Have Lower Hypoaesthesia Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE